Wallin, M. T. et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 269–285 (2019).
Miller, A. E. et al. Autologous hematopoietic stem cell transplant in multiple sclerosis: recommendations of the national multiple sclerosis society. JAMA Neurol. 78, 241–246 (2021).
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B. G. Multiple sclerosis. N. Engl. J. Med. 343, 938–952 (2000).
Article CAS PubMed Google Scholar
Yong, H. Y. F. & Yong, V. W. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis. Nat. Rev. Neurol. 18, 40–55 (2022).
Article CAS PubMed Google Scholar
Mancardi, G. L. et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology 84, 981–988 (2015).
Article CAS PubMed Google Scholar
Nash, R. A. et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurol. 72, 159–169 (2015).
Article PubMed PubMed Central Google Scholar
Atkins, H. L. et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet 388, 576–585 (2016).
Moore, J. J. et al. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 90, 514–521 (2019).
Burt, R. K. et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing–remitting multiple sclerosis: a randomized clinical trial. JAMA 321, 165–174 (2019).
Article PubMed PubMed Central Google Scholar
Muraro, P. A. et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J. Exp. Med. 201, 805–816 (2005).
Article CAS PubMed PubMed Central Google Scholar
Muraro, P. A. et al. T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J. Clin. Invest. 124, 1168–1172 (2014).
Article CAS PubMed PubMed Central Google Scholar
Massey, J. et al. Haematopoietic stem cell transplantation results in extensive remodelling of the clonal T cell repertoire in multiple sclerosis. Front. Immunol. 13, 798300 (2022).
Article CAS PubMed PubMed Central Google Scholar
Ruder, J. et al. Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis. Sci. Transl. Med. 14, eabq1693 (2022).
Article CAS PubMed Google Scholar
Gold, R. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006).
Psenicka, M. W., Smith, B. C., Tinkey, R. A. & Williams, J. L. Connecting neuroinflammation and neurodegeneration in multiple sclerosis: Are oligodendrocyte precursor cells a nexus of disease? Front. Cell. Neurosci. 15, 654284 (2021).
Article CAS PubMed PubMed Central Google Scholar
Williams, J. L. et al. Astrocyte–T cell crosstalk regulates region‐specific neuroinflammation. Glia 68, 1361–1374 (2020).
Article PubMed PubMed Central Google Scholar
Meijer, M. et al. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron 110, 1193–1210.e13 (2022).
Article CAS PubMed PubMed Central Google Scholar
Ajami, B. et al. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat. Neurosci. 21, 541–551 (2018).
Article CAS PubMed PubMed Central Google Scholar
Guerrero, B. L. & Sicotte, N. L. Microglia in multiple sclerosis: Friend or foe? Front. Immunol. 11, 374 (2020).
Article CAS PubMed PubMed Central Google Scholar
Miron, V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211–1218 (2013).
Article CAS PubMed PubMed Central Google Scholar
Lampron, A. et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J. Exp. Med. 212, 481–495 (2015).
Article CAS PubMed PubMed Central Google Scholar
Falcão, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837–1844 (2018).
Article PubMed PubMed Central Google Scholar
Jordão, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).
Sailor, K. A. et al. Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain. Nat. Med. 28, 517–527 (2022).
Article CAS PubMed Google Scholar
Shibuya, Y. et al. Treatment of a genetic brain disease by CNS-wide microglia replacement. Sci. Transl. Med. 14, eabl9945 (2022).
Article CAS PubMed PubMed Central Google Scholar
DeTomaso, D. et al. Functional interpretation of single cell similarity maps. Nat. Commun. 10, 4376 (2019).
Article PubMed PubMed Central ADS Google Scholar
Hahn, O. et al. Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell 186, 4117–4133.e22 (2023).
Article CAS PubMed Google Scholar
International Multiple Sclerosis Genetics Consortium et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).
Article PubMed Central Google Scholar
Trobisch, T. et al. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis. Acta Neuropathol. 144, 987–1003 (2022).
Article CAS PubMed PubMed Central Google Scholar
Absinta, M. et al. A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis. Nature 597, 709–714 (2021).
Article CAS PubMed PubMed Central ADS Google Scholar
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2019).
Article CAS PubMed PubMed Central ADS Google Scholar
Jäkel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543–547 (2019).
Article PubMed PubMed Central ADS Google Scholar
Hohsfield, L. A. et al. Effects of long-term and brain-wide colonization of peripheral bone marrow-derived myeloid cells in the CNS. J. Neuroinflammation 17, 279 (2020).
Article CAS PubMed PubMed Central Google Scholar
Xu, Z. et al. Efficient strategies for microglia replacement in the central nervous system. Cell Rep. 32, 108041 (2020).
Article CAS PubMed Google Scholar
Cronk, J. C. et al. Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia. J. Exp. Med. 215, 1627–1647 (2018).
Article CAS PubMed PubMed Central Google Scholar
Lee, H. K. et al. Daam2-PIP5K Is a regulatory pathway for Wnt signaling and therapeutic target for remyelination in the CNS. Neuron 85, 1227–1243 (2015).
留言 (0)